The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular Atrophy

Abstract excerpt

Spinal muscular atrophy (SMA) is a rare, autosomal recessive neuromuscular degenerative disease characterized by loss of spinal cord motor neurons leading to progressive muscle wasting. The most common pathology results from a homozygous disruption in the survival motor neuron 1 (SMN1) gene on chromosome 5q13 via deletion, conversion, or mutation. SMN2 is a near duplicate of SMN1 that can produce full-length SMN...

Topics

Join the communities discussing this publication.

• Congenital Anomalies and Fetal Surgery
• Neurogenetic and Muscular Disorders Research
• RNA modifications and cancer